Lin Liu

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom et al. · The Lancet · 2025 · 64 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Cyclodextrin-Coordinated Liposome-in-Gel for Transcutaneous Quercetin Delivery for Psoriasis Treatment

Yuqin Zhang, Shuqing Gong, Lin Liu et al. · ACS Applied Materials & Interfaces · 2023 · 52 citations

Pharmacy, Dermatology, Pharmacology +17

Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ

Qian Zeng, Tingting Zhou, Wenjie Huang et al. · Scientific Reports · 2023 · 18 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Relief of gouty arthritis in rats by total saponins from<i> Dioscorea nipponica</i> Makino through suppression of neutrophil extracellular trap formation via the PI3K/AKT/mTOR axis

Qi Zhou, Lin Liu, Huijuan Sun et al. · Experimental and Therapeutic Medicine · 2023 · 13 citations · Full text

Medicine, Immunology, Pharmacology +17

Safety and efficacy of peficitinib in Asian patients with rheumatoid arthritis who had an inadequate response or intolerance to methotrexate: results of a multicenter, randomized, double-blind, placebo-controlled phase 3 study

Yue Yang, Jingyang Li, Ju Liu et al. · The Lancet Regional Health - Western Pacific · 2023 · 10 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14